Research Article
Population Management: A Tool to Improve Timely Care in Pediatric and Young Adult Patients with Inflammatory Bowel Disease
Table 1
CHAM IBD patient demographics.
| Variable | No. (%) |
| Age | | 0-5 | 1 (1%) | 6-10 | 7 (8%) | 11-14 | 13 (15%) | 15-17 | 24 (29%) | 18-21 | 39 (46%) | Gender | | Female | 34 (40%) | Male | 50 (60%) | Race/ethnicity | | Hispanic | 30 (36%) | White | 22 (26%) | Black | 17 (20%) | Asian | 2 (2%) | Pacific Islander | 1 (1%) | Multiracial | 1 (1%) | Not disclosed | 11(13%) | Diagnosis | | Crohn’s | 55 (65%) | Ulcerative colitis | 25 (30%) | Indeterminate | 4 (5%) | Treatment | | Anti-TNF | 31 (37%) | Immunomodulator | 30 (35%) | 5-ASA | 18 (21%) | Other | 5 (6%) |
|
|